ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
- Status
- COMPLETED
- Phase
- N/A
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE4
Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
- Status
- RECRUITING
- Phase
- NA
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study
- Status
- RECRUITING
- Phase
- NA
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2